NCT01647542View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes

PHASE3TerminatedINTERVENTIONAL
Enrollment

393

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

TAK-875

TAK-875 tablets

DRUG

TAK-875 Placebo

TAK-875 placebo-matching tablets

Trial Locations (51)

Unknown

Brookvale

Maroubra

Mosman

Woy Woy

Elizabeth Vale

Hefei

Beijing

Beijing,P.R.

Chongqing

Fuzhou

Xiamen

Guangzhou

Guiyang

Shijiazhuang

Harbin

Wuhan

Changsha

Chenzhou

Nanjing

Suzhou

Changchun

Changchun City, Jilin Province

Xi'an

Shanghai

Xi’an

Chengdu

Tianjin

Beijing

Chongqing

Guangzhou

Guiyang

Heilongjiang

Nanjing

Shanghai

Tianjin

Auckland

Hamilton

Rotorua

Tauranga

Wellington

Goyang-si

Seongnam-si

Suwon

Gyeonggi-do

Incheon

Seoul

Kaohsiung City

New Taipei City

Taichung

Tainan City

Taipei

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY